Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia

Keyphrases

• Allogeneic Bone Marrow Transplantation 100%
• Acute Myeloblastic Leukemia 100%
• Therapy-related Myelodysplastic Syndrome (t-MDS) 100%
• Myelodysplastic Syndrome 50%
• Reciprocal Translocation 50%
• Long Arm 25%
• Bone Marrow 25%
• Chromosome 7 25%
• Spectral Karyotyping 25%
• Neutrophils 25%
• 9q34 25%
• Translocated 25%
• Stem Cell Transplantation 25%
• Older Women 25%
• Normal Karyotype 25%
• Complete Remission 25%
• Megakaryocytes 25%
• Chromosomal Aberrations 25%
• Chromosome Analysis 25%
• Allogeneic Transplantation 25%
• Fluorescence in Situ Hybridization Analysis 25%
• Myeloid Malignancies 25%
• Complex Karyotype 25%
• Pancytopenia 25%
• Myeloblasts 25%
• Recurrent Translocation 25%
• Cytogenetic Aberrations 25%
• Metaphase Spread 25%
• 7q31 25%
• Male Donor 25%
• Dysplastic Changes 25%

Biochemistry, Genetics and Molecular Biology

• Karyotype 100%
• Reciprocal Chromosome Translocation 100%
• Stem Cell Transplantation 50%
• Chromosome 7 50%
• Spectral Karyotyping 50%
• Cytogenetics 50%
• Myeloid 50%
• Neutrophil Granulocyte 50%
• Fluorescence in Situ Hybridization 50%
• Metaphase 50%
• Chromosomal Aberration 50%
• ABL (Gene) 50%
• Megakaryocyte 50%
• Myeloblast 50%

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Myelodysplastic Syndrome 100%
• Allogenic Bone Marrow Transplantation 100%
• Karyotype 50%
• Reciprocal Chromosome Translocation 50%
• Arm 25%
• Chromosome Aberration 25%
• Stem Cell Therapy 25%
• Allograft 25%
• Neutrophil 25%
• Megakaryocyte 25%
• Chromosome Analysis 25%
• Fluorescence in Situ Hybridization 25%
• Metaphase 25%
• Pancytopenia 25%
• Chromosome 7 25%
• Myeloid Malignancy 25%
• Myeloblast 25%